A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Clinical trial NCT07188558 · RECRUITING

Trial details

NCT number: NCT07188558
Sponsor: Lyell Immunopharma, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Large B-cell Lymphoma Lymphoma, B-Cell Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma Refractory/ Relapsed Diffuse Large B Cell Lymphoma (DLBCL)Diffuse Large B Cell Lymphoma Refractory Diffuse Large B Cell Lymphoma Relapsed

Start date: 2026-01-12
Primary completion: 2029-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.